	净收入		日
Acadia Pharmaceuticals	USD 273.57M	201.79M	2025-12
Agios Pharmaceuticals	USD -99.11M	8.93M	2026-03
Alnylam Pharmaceuticals	USD 205.99M	19.57M	2026-03
BioCryst Pharmaceuticals	USD 245.84M	232.95M	2025-12
BioMarin Pharmaceutical	USD 105.53M	152.1M	2026-03
Esperion Therapeutics	USD 61.83M	93.16M	2025-12
Immunic	USD -19.3M	6.28M	2025-12
Insmed	USD -328.48M	41.54M	2025-12
Ionis Pharmaceuticals	USD -93M	136M	2026-03
Karyopharm Therapeutics	USD -102.2M	71.42M	2025-12
Kyowa Hakko Kirin	JPY 34.44B	18.16B	2025-12
MacroGenics	USD -14.16M	30.98M	2025-12
Moderna	USD -1.34B	517M	2026-03
Neurocrine Biosciences	USD 153.7M	55.8M	2025-12
PTC Therapeutics	USD -134.96M	150.86M	2025-12
Puma Biotechnology	USD 20.32M	24.85M	2024-09
Regeneron Pharmaceuticals	USD 727.2M	117.4M	2026-03
Sarepta Therapeutics	USD -412.23M	232.28M	2025-12
Ultragenyx Pharmaceutical	USD -129M	51.41M	2025-12
Vertex Pharmaceuticals	USD 1.03B	159.7M	2026-03
Xoma	USD -17.24M	33.23M	2024-09